420 likes | 561 Views
SPK Pancreas Graft Function. USA Primary DD Pancreas Transplants, 10/1/1987 – 12/31/2010. 3/11. SPK Pancreas Graft Function. USA Primary DD Pancreas Transplants, 10/1/1987 – 12/31/2010. 3/11. SPK Kidney Graft Function. USA Primary DD Pancreas Transplants, 10/1/1987 – 12/31/2010. 3/11.
E N D
SPK Pancreas Graft Function USA Primary DD Pancreas Transplants, 10/1/1987 –12/31/2010 3/11
SPK Pancreas Graft Function USA Primary DD Pancreas Transplants, 10/1/1987 – 12/31/2010 3/11
SPK Kidney Graft Function USA Primary DD Pancreas Transplants, 10/1/1987 –12/31/2010 3/11
SPK Kidney Graft Function USA Primary DD Pancreas Transplants, 10/1/1987 –12/31/2010 3/11
PAK Pancreas Graft Function USA Primary DD Pancreas Transplants, 10/1/1987 –12/31/2010 3/11
Re-PAK Pancreas Graft Function USA Second DD Pancreas Transplants, 10/1/1987 –12/31/2010 3/11
PAK Pancreas Graft Function USA Primary DD Pancreas Transplants, 1/1/1988 –12/31/2009 3/11
PTA Pancreas Graft Function USA Primary DD Pancreas Transplants, 10/1/1987 – 12/31/2010 3/11
PTA Pancreas Graft Function USA DD Primary Pancreas Transplants, 10/1/1987 – 12/31/2010 3/11
Kidney Transplants after PTA USA Primary DD Pancreas Transplants, 10/1/1987 – 12/31/2010 3/11
ReTx Rate after Primary PAK USA Primary DD Pancreas Transplants, 10/1/1987 – 12/31/2010 3/11
ReTx Rate after Primary PTA USA Primary DD Pancreas Transplants, 10/1/1987 – 12/31/2010 3/11
ReTx Rate after Primary SPK USA Primary DD Pancreas Transplants, 10/1/1987 – 12/31/2010 3/11
1-Year Unadjusted Patient Survival USA Primary DD Pancreas Transplants, 1/1/1988 – 12/31/2010 3/11
5-Year Unadjusted Patient Survival USA Primary DD Pancreas Transplants, 1 /1/1988 – 12/31/2009 3/10
10-Year UnadjustedPatient Survival USA DD Primary Pancreas Transplants, 1 /1/1988 – 12/31/2009 3/10
1-Year Pancreas/Kidney Graft Function USA Primary DD Pancreas Transplants, 10/1/1988 – 12/31/2010 2/11
5-Year Pancreas/Kidney Graft Function USA DD Primary Pancreas Transplants, 1/1/1988 – 12/31/2010 3/11
10-Year Pancreas/Kidney Graft Function USA Primary DD Pancreas Transplants, 1/1/1988 – 12/31/2010 3/11
Early Technical Pancreas Graft Failures USA DD Primary Pancreas Transplants, 1/1/1988 – 12/31/2010 3/11
Early Technical Pancreas Graft Failures USA DD Primary Pancreas Transplants, 1/1/1988 – 12/31/2010 3/11
1 Year Immunological Pancreas Graft Failures USA DD Primary Pancreas Transplants, 1/1/1988 – 12/31/2010 3/11
1-Year Immunological Graft Loss USA DD Primary TS Pancreas Transplants, 1/1/1988 – 12/31/2010 3/11
5-Year Immunological Graft Loss USA DD Primary TS Pancreas Transplants, 1/1/1988 – 12/31/2009 3/10
Early Technical Pancreas Graft Failures USA DD Primary Pancreas Transplants, 1/1/1988 – 12/31/2009 SPK PAK PTA Transplant Year 3/10
1-Year Pancreas Graft Function USA DD Primary Pancreas Transplants, 1/1/1988 – 12/31/2010 SPK PAK PTA Transplant Year 3/11
1-Year Immunological Pancreas Graft Loss Rate USA DD Primary TS Pancreas Transplants, 1/1/1988 – 12/31/2009 SPK PTA PAK Transplant Year 3/10
5-Year Pancreas Graft Function USA DD Primary Pancreas Transplants, 1/1/1988 – 12/31/2009 PAK PTA SPK 2/09
Patient Survival USA Primary DD Pancreas Transplants 1/1/2006 – 12/31/2010 Category n 1Yr Surv. PTA 43396.4% PAK 80096.0% SPK 4,12995.8% 3/11
PAK Patient Survival by Kidney Donor Type USA DD Primary Pancreas Transplants 1/1/2005 – 12/31/2009 Kidney Dnr n 1Yr Surv. LD 672 97.2% DD 26495.8% p <0.01 3/10
Major Causes of Patient Death USA Primary DD Pancreas Transplants 1/1/2005 – 12/31/2009 % SPK PAK PTA 0-3 3-12 > 12 0-3 3-12 > 12 0-3 3-12 > 12 Months Posttransplant 3/10
Pancreas Graft Function USA DD Primary Pancreas Transplants 1/1/2006 – 12/31/2010 DwFxPancreas censored Cat. n 1Yr Fxn SPK 4,122 88.4% PAK79882.6% PTA 43379.9% p < 0.0001 3/11
SPK Pancreas Graft Fxn by Donor Type USA DD Primary Pancreas Transplants 1/1/2005 – 12/31/2009 Donor n 1Yr Surv. Non-Hrt-Dnr11689.0% Standard 4,030 84.9% p = 0.28 3/10
Pancreas Graft Function USA DD Primary Pancreas Transplants 1/1/2005 – 12/31/2010 Cat. n 1Yr Fxn SPK 4,12285.5% PAK 79879.9% PTA 43377.8% p < 0.0001 3/11
Pancreas Graft Function USA DD Primary Pancreas Transplants 1/1/2005 – 12/31/2009 Anti-T-Cell Therapy & TAC & MMF Cat. n 1Yr Fxn PAK 54481.3% PTA 27185.6% SPK 2,73786.3% 3/10
Pancreas Graft Function USA DD Primary Pancreas Transplants 1/1/2005 – 12/31/2009 Anti-T-Cell Therapy & Sirolimus based Protocol Cat. n 1Yr Fxn PAK 9589.3% PTA 8790.2% SPK 40789.6% 3/10
Major Causes of Px Graft Failure USA Primary DD Pancreas Transplants 1/1/2005 – 12/31/2009 % SPK PAK PTA 0-<3 3-<12 ≥ 12 0-<3 3-<12 ≥ 12 0-<3 3-<12 ≥12 Months Posttransplant 3/09
Early Technical Failure Rate USA Primary DD Pancreas Transplants 1/1/2006 – 12/31/2010 * * P = 0.01
Reasons for Early Technical Failures USA Primary DD Pancreas Transplants 1/1/2005 – 12/31/2009 3/10
Early Technical Failures USA Primary DD ED Pancreas Transplants 1/1/2005 – 12/31/2009 3/10
Immunological Pancreas Graft Loss USA Primary TS DD Pancreas Transplants 1/1/2005 – 12/31/2009 p = 0.0001 Category n 1Yr Loss PTA 413 6.0% PAK 811 5.5% SPK 3,687 2.1% 3/10